Insider Transactions in Q4 2021 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2021
|
M Kathleen Behrens |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.56%
|
$50,000
$10.08 P/Share
|
|
Dec 10
2021
|
Mary Ann Gray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
967
+9.33%
|
-
|
|
Nov 24
2021
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Open market or private purchase
|
Direct |
3,780
+5.44%
|
$298,620
$79.33 P/Share
|
|
Nov 17
2021
|
Douglas S Ingram President & CEO |
BUY
Open market or private purchase
|
Direct |
25,026
+6.42%
|
$1,977,054
$79.94 P/Share
|
|
Nov 16
2021
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+39.25%
|
-
|
|
Nov 16
2021
|
Stephen Mayo |
BUY
Grant, award, or other acquisition
|
Direct |
4,292
+50.0%
|
-
|